Exactitude Consultancy latest Press Release 2023: Global Electroceuticals And Bioelectric medicine market

Technological Advancements In The Electroceutical Field Are Propelling The Growth Of The Electroceutical Medicine Market.

Electroceuticals are medical devices that help to treat a variety of medical conditions by targeting specific nerve fibers or brain circuits. The technologies alter brain impulses that control a variety of voluntary and involuntary movements in the human body, restoring lost function and re-establishing a healthy balance. Diabetes, hypertension, heart failure, vascular disease, and lung problems are just a few of the serious illnesses that electroceuticals have the potential to cure. These devices could not only treat severe illnesses, but also do so in a safe and non-invasive manner. There are several electroceutical devices on the market that use electric impulses to treat a variety of illnesses, such as pacemakers and defibrillators. The potential benefits of electroceuticals make such new medical technologies an intriguing advancement.

The Rise In Lifestyle Disorders Is Expected To Drive Up Demand For The Electroceuticals And Bioelectric Medicine Market.

As global disposable income and urbanization rise, more people are adopting sedentary lifestyles. Obesity, hypertension, and diabetes are on the rise as a result of this. Around 39% of the global adult population is overweight, and 9.8% has diabetes. Furthermore, hypertension affects 26% of the population, with a projected increase to 29% by 2025. This is causing a rapid increase in cardiovascular disorders, which is driving demand. In the United States, for example, approximately 659,000 people die each year as a result of heart disease. According to the World Health Organization, ischemic heart disease is responsible for 16% of all deaths worldwide, making it the leading cause of death.

Explore 155 market data Tables spread through nearly 108 Pages and in-depth analysis on “Electroceuticals and Bioelectric Medicine Market by Product (Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Vagus Nerve Stimulators and Others Product Types.),Device (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), Application (Arrhythmia, Pain management, Parkinson’s Disease, Sensorineural Hearing Loss, Depression, and Others.), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users) and by Region Global Trends and Forecast from 2022 to 2029″ with Table of Content – Click here

Cardiac Pacemakers And Icds Will Drive Global Demand For Electroceuticals And Bioelectric Medicine Market.

The global electroceuticals and bioelectric medicine market is divided into cardiac pacemakers & ICDs, cochlear implants, spinal cord stimulators, deep brain stimulators, and other product types. Because of the rising prevalence of cardiovascular disorders worldwide, the cardiac pacemakers and ICDs segment is expected to account for a dominant market share throughout the forecast period. Over the next four years, the geriatric population, which is more prone to cardiac diseases, is expected to supplement demand for cardiac pacemakers and ICDs. Over the forecast period, the growing aging population is expected to drive demand for cochlear implants.

 The Implantable Electroceutical Devices Segment Held The Largest Share Of The Electroceuticals And Bioelectric Medicine Market.

On the basis of type, the market is divided into implantable electroceutical devices and non-invasive electroceutical devices. The implantable electroceutical devices segment held the largest share in 2020. The rising incidence of neurological and cardiovascular disorders, as well as an increase in the number of product approvals, are driving the growth of this segment.

The Presence Of Large Industry Players Carrying Out Strategic Initiatives Will Drive Market Share.

The major players operating in the global electroceuticals/bioelectric medicine include Sonova Holding AG, LivaNova PLC, Soterix Medical Inc., NeuroPace Inc., Stimwave LLC, Vomaris Innovations Inc., Nevro Corporation, Biotronik, Second Sight Medical Products Inc., Oticon Medical, Boston Scientific Corporation, St. Jude Medical, GiMer Medical, Cochlear Limited, ElectroCore LLC, BioElectronics Corporation, MED-EL, Set Point Medical, Cefaly Technology, Medtronic plc., EnteroMedics Inc., BioWave Corporation, NeuroSigma Inc. and others. The presence of established industry players and is characterized by mergers and acquisitions, joint ventures, capacity expansions, substantial distribution, and branding decisions to improve market share and regional presence. Also, they are involved in continuous R&D activities to develop new products as well as are focused on expanding the product portfolio. This is expected to intensify competition and pose a potential threat to the new players entering the market.

North America Is Expected To Have The Largest Market Share In The Overall Electroceuticals And Bioelectric Medicine Market.

 The North American region dominates in terms of significantly different technological advancement. The same is true for the bioelectric medicine market. In terms of revenue, the North American region dominates the bioelectric medicines market. This region is home to the majority of major corporations, which consistently provide cutting-edge health-care facilities and equipment. These factors are critical for the growth of the market in this region.

Due to its developed healthcare infrastructure and rapid adoption of novel technologies, the United States electroceuticals and bioelectric medicine market is expected to emerge as a highly lucrative market for key companies as well as aspiring startups. High R&D spending in the country is also expected to drive electroceutical and bioelectric medicine sales through 2029. Government initiatives are expected to boost demand for Electroceuticals And Bioelectric Medicine even more.

Electroceuticals and Bioelectric Medicine Market Players

The global Electroceuticals and Bioelectric medicine market key players include Sonova Holding AG, LivaNova PLC, Soterix Medical Inc., NeuroPace Inc., Stimwave LLC, Vomaris Innovations Inc., Nevro Corporation, Biotronik, Second Sight Medical Products Inc., Oticon Medical, Boston Scientific Corporation, St. Jude Medical, GiMer Medical, Cochlear Limited, ElectroCore LLC, BioElectronics Corporation, MED-EL, Set Point Medical, Cefaly Technology, Medtronic plc., EnteroMedics Inc., BioWave Corporation, NeuroSigma Inc.

Key Market Segments: Electroceuticals and Bioelectric Medicine Market

Electroceuticals And Bioelectric Medicine Market By Product Type, 2020-2029, (Usd Billion)

Cardiac Pacemakers & Icds

Cochlear Implants

Spinal Cord Stimulators

Deep Brain Stimulators

Transcutaneous Electrical Nerve Stimulators

Vagus Nerve Stimulators

Other Product Types

Electroceuticals And Bioelectric Medicine Market By Device, 2020-2029, (Usd Billion)

Implantable Electroceutical Devices

Noninvasive Electroceutical Devices

Electroceuticals And Bioelectric Medicine Market By Application, 2020-2029, (Usd Billion)

Arrhythmia

Pain Management

Parkinson’s Disease

Sensorineural Hearing Loss

Depression

Others

Electroceuticals And Bioelectric Medicine Market By End-User 2020-2029, (Usd Billion)

Hospitals

Clinics

Ambulatory Surgical Centers

Other End Users

Electroceuticals And Bioelectric Medicine Market By Region, 2020-2029, (Usd Billion)

North America

Europe

Asia Pacific

South America

Middle East And Africa

Important Countries In All Regions Are Covered.

The post Electroceutical Medicine Market electroceuticals make such new medical technologies an intriguing advancement appeared first on Exactitude Consultancy.